SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-21-113150
Filing Date
2021-04-12
Accepted
2021-04-12 16:04:31
Documents
4
Period of Report
2021-05-13

Document Format Files

Seq Description Document Type Size
1 DEF 14A d162618ddef14a.htm DEF 14A 407856
2 GRAPHIC g162618g03v16.jpg GRAPHIC 42170
3 GRAPHIC g162618g11i11.jpg GRAPHIC 312998
4 GRAPHIC g162618g22i22.jpg GRAPHIC 322425
  Complete submission text file 0001193125-21-113150.txt   1338166
Mailing Address 260 SHERIDAN AVENUE SUITE 400 PALO ALTO CA 94306
Business Address 260 SHERIDAN AVENUE SUITE 400 PALO ALTO CA 94306 650-800-6676
Vincerx Pharma, Inc. (Filer) CIK: 0001796129 (see all company filings)

IRS No.: 833197402 | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-39244 | Film No.: 21820759
SIC: 2834 Pharmaceutical Preparations